Stock Info Nets

Independent Financial Information Made Easy

Our AI creates

The Best Stock Graphs and Charts

Youtube Subscribe Blog GamificArt

The development of Artificial Intelligence (AI) is modifying the way investments are evaluated. We programmed an artificial intelligence (A.I.) to summarize the whole internet. Whether you’re trying to make money investing online, making financial decisions or just getting informed about Wall Street, this page is a way to get informed without reading hundred of pages. Our stock market summary graphs are produced using machine learning, an unbiased view to capture what internet is saying. Usually, the AI reads several hundred pages and summarize it to a short text and several charts.

General Description

Novavax

Youtube Subscribe

...

Ticker: NVAX

Sector: Biotechnology

Novavax, Inc. promotes improved health by discovering, developing, and commercializing vaccines. Company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid.
...
...
Extended Summary

Novavax

Novavax, Inc., a biotechnology company, that promotes improved health by discovering, developing, and commercializing vaccines to protect against serious infectious diseases. It offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. It focuses on urgent health challenges, which is evaluating vaccines for COVID-19, influenza, and COVID-19 and influenza combined. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, Adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It is also focusing on products candidates for respiratory syncytial virus and malaria. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.

Related Results

...
January 13, 2024 17:09 (London Time)

Novavax

Wall Street analyst Vernon Bernardino foresees shares of Novavax catapulting to $35. Wall Street analysts believe shares could reach $35.
Sector: Biotechnology
Ticker: NVAX
Sentiment: 0.959
MarketCap: 544,653,167.0
High: 4.73 Low: 4.53

Open: 4.56 Close: 4.58 Change: 0.02

Read more →
...
August 26, 2023 3:22 (London Time)

Novavax

Pfizer, Moderna and Novavax are expected to bring out new Covid vaccines in mid-September. Updated Covid shots are designed to target XBB.1.5, the O…
Sector: Biotechnology
Ticker: NVAX
Sentiment: 0.5267
MarketCap: 812,278,689.0
High: 8.32 Low: 8.0

Open: 8.24 Close: 8.05 Change: -0.19

Read more →
...
May 27, 2023 14:44 (London Time)

Novavax

COVID-19 vaccine maker Novavax is cutting about a quarter of its global workforce. Company expects to trim next years costs for research and develop…
Sector: Biotechnology
Ticker: NVAX
Sentiment: 0.5719
MarketCap: 729,272,036.0
High: 7.27 Low: 6.8

Open: 6.92 Close: 7.21 Change: 0.29

Read more →
...
April 29, 2023 9:44 (London Time)

Novavax

Novavax (NVAX) stock could surge almost 12 times in the next year. The biotechnology company reported fourth-quarter earnings and a issued going con…
Sector: Biotechnology
Ticker: NVAX
Sentiment: 0.8441
MarketCap: 660,948,480
High: 7.77 Low: 7.33

Open: 7.46 Close: 7.67 Change: 0.21

Read more →
...
September 14, 2023 8:44 (London Time)

Novavax

Pfizer-BioNTech and Moderna have new vaccines that were approved on Monday. Pfizer and Modernas are rolling out now, with Novavax likely to follow. …
Sector: Biotechnology
Ticker: NVAX
Sentiment: 0.7579
MarketCap: 742,654,801.0
High: 7.93 Low: 7.34

Open: 7.89 Close: 7.36 Change: -0.53

Read more →
...
May 28, 2023 14:39 (London Time)

Novavax

Novavax and Moderna enjoy the biggest positive CAARs (241.42% and 110.29%) The reaction of the stock markets to news about the pandemic or the vacci…
Sector: Biotechnology
Ticker: NVAX
Sentiment: 0.9188
MarketCap: 729,272,036.0
High: 7.27 Low: 6.8

Open: 6.92 Close: 7.21 Change: 0.29

Read more →
...
May 23, 2023 19:00 (London Time)

Novavax

Novavax reported a loss per share of $3.41 per share versus the Zacks Consensus Estimate of $ 3.38. Company still reported bleak first-quarter earni…
Sector: Biotechnology
Ticker: NVAX
Sentiment: 0.7322
MarketCap: 729,272,036.0
High: 8.16 Low: 7.42

Open: 7.56 Close: 8.07 Change: 0.51

Read more →
Search
Happening Now
Categories